Fusing biotechnology and product innovation

Recent years have seen the market opportunity for innovative bioscience products grow rapidly. For instance, the human clinical diagnostics field is now a $17 billion world‐wide market, and in specific sectors, such as point of care (POC) and over the counter (OTC), there is an increasing emphasis on novel device and chemistry design. Pharmaceuticals is an even more massive $200 billion market world‐wide, where major opportunities for innovative products lie in combinations of pharmaceuticals with diagnostics and in advanced drug delivery systems.